Death induced by CD95 or CD95 ligand elimination. Academic Article uri icon

Overview

abstract

  • CD95 (Fas/APO-1), when bound by its cognate ligand CD95L, induces cells to die by apoptosis. We now show that elimination of CD95 or CD95L results in a form of cell death that is independent of caspase-8, RIPK1/MLKL, and p53, is not inhibited by Bcl-xL expression, and preferentially affects cancer cells. All tumors that formed in mouse models of low-grade serous ovarian cancer or chemically induced liver cancer with tissue-specific deletion of CD95 still expressed CD95, suggesting that cancer cannot form in the absence of CD95. Death induced by CD95R/L elimination (DICE) is characterized by an increase in cell size, production of mitochondrial ROS, and DNA damage. It resembles a necrotic form of mitotic catastrophe. No single drug was found to completely block this form of cell death, and it could also not be blocked by the knockdown of a single gene, making it a promising way to kill cancer cells.

publication date

  • March 20, 2014

Research

keywords

  • Fas Ligand Protein
  • Neoplasms
  • fas Receptor

Identity

PubMed Central ID

  • PMC4083055

Scopus Document Identifier

  • 84898024383

Digital Object Identifier (DOI)

  • 10.1016/j.celrep.2014.02.035

PubMed ID

  • 24656822

Additional Document Info

volume

  • 7

issue

  • 1